One of the more aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in it's late stages when it is extremely hard to do anything about it.
As the side effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumors are always malignant, and mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer ends in death.
Though the possibilities of neuroendocrine carcinoma in colon are rare at best if one is affected the patient's condition becomes much worse than patients who suffer from adenocarcinoma.
Research reveals that the results of this form of cancer do not differ with age, sex or tumor location. Though neuroendocrine colon carcinoma depends on which stage the tumor is in The usual trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. But alternately in the majority of cases if said tumor is in stage 3 or 4, it is a laborious and and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has few techniques to deal with this particular cancer. A more common technique that the doctors often use is immunohistochemical staining methods. this method assists the doctors to detect the severity of the neuroendocrine colon cancer and really helps determine the most helpful medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of said tumor with an antibody called A-80 which helps in identifying the quantum of neuroendocrine differentiation and nature of the damage on the patient's health.
Neuroendocrine colon carcinoma is cumbersome to deal with and in a certain study in which a number of patients suffered from colon carcinoma were extensively examined it was observed that the overall survival rate related to this disease was approximately seven months. In the later stages these rates decrease, to as low as five months or less. Most cases were at first found to be as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not a cent percent guaranteed treatment so surgery may not even provide a satisfactory cure. so it is critical to detect this disease on time and provide proper medication for it.
As the side effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumors are always malignant, and mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer ends in death.
Though the possibilities of neuroendocrine carcinoma in colon are rare at best if one is affected the patient's condition becomes much worse than patients who suffer from adenocarcinoma.
Research reveals that the results of this form of cancer do not differ with age, sex or tumor location. Though neuroendocrine colon carcinoma depends on which stage the tumor is in The usual trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. But alternately in the majority of cases if said tumor is in stage 3 or 4, it is a laborious and and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has few techniques to deal with this particular cancer. A more common technique that the doctors often use is immunohistochemical staining methods. this method assists the doctors to detect the severity of the neuroendocrine colon cancer and really helps determine the most helpful medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of said tumor with an antibody called A-80 which helps in identifying the quantum of neuroendocrine differentiation and nature of the damage on the patient's health.
Neuroendocrine colon carcinoma is cumbersome to deal with and in a certain study in which a number of patients suffered from colon carcinoma were extensively examined it was observed that the overall survival rate related to this disease was approximately seven months. In the later stages these rates decrease, to as low as five months or less. Most cases were at first found to be as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not a cent percent guaranteed treatment so surgery may not even provide a satisfactory cure. so it is critical to detect this disease on time and provide proper medication for it.
About the Author:
It's time to clear things up on the subject of Colon clenz. Drop by today at ultra colon clenz.
0 comments:
Post a Comment